InfoStrength software was the result of the years of experience and knowledge of its founders regarding the needs of the life science industry. The software is tailored to cater and support life-science businesses in the areas of product design, development, commercialization, and operations management among others. The solution allows companies to manage critical business operations and control content from one place. Rita King, CEO and Senior Regulatory Consultant, explains, “Our platform enables our clients to safely and securely share information and collaborate with their suppliers and partners while retaining control of their IP and addressing multiple international regulations.”
MethodSense's consultants adapt to varied client needs and deliver services that effectively meet global regulatory requirements.
In the life sciences industry, information management is not only about the preservation of data, but also about IP protection. InfoStrength enables its clients to meet regulatory requirements of ISO 9000, FDA 21 CFR Part 11, Part 820 Quality System Regulation, ISO 13485 and Annex 11 effectively. The company maintains data integrity throughout the development, implementation, and maintenance of design controls. Though these restrictions are mandatory and stipulated by the industry regulations, MethodSense customizes them for the specific needs of the business through a variety of product offerings. As a software product developer and regulatory consultants, MethodSense is well versed in enforcing software development life-cycle requirements and methodologies, and in implementing software risk management and validation, which have become instrumental for clients who integrate software into their products.
Abiding by its guiding principles of always seeking opportunities to learn and the core belief that a team is stronger than an individual, MethodSense employs a vibrant team that works tirelessly to help their clients become acquainted with FDA and other regulatory norms in the life-sciences industry. The team has successfully supported organizations with sophisticated medical devices with their combination of software and services. For an international medical device company, MethodSense helped identify and develop a product that, through its commercialization, strengthened a partnership with a large pharmaceutical company and created early market entry opportunities for the client and their partner. MethodSense identified the necessary deliverables that were required to bring the product to the market and managed the strategy to attain product realization. The company completed the combination project from initiation to FDA clearance within 12 months, enabling the client to generate profits within the first year of product commercialization.
Recently, MethodSense guided a team of engineers through the commercialization process of a medical device. Taking care of the development of a quality management system, product lifecycle, risk management, and human factors validation, the company helped the client to bring the product to the market in 18 months. In the near future, MethodSense aspires to be a recognized leader in the life science space while executing growth plans with an unwavering focus on client success.